Posts With Tag Kazia Therapeutics

Kazia Therapeutics secures a Michael J. Fox Foundation grant for Paxalisib research, enhancing its position in the biotech sector. Insights on growth and strategic partnerships included.

Explore Kazia Therapeutics Limited's latest Form 6-K report detailing a $1.7M fundraising strategy through registered offerings and private placements for growth and development.

Discover Kazia Therapeutics' latest Form 6-K filing, featuring a crucial update on Paxalisib's regulatory pathway and FDA discussions. Stay informed on their strategic developments.